Conmed (CNMD) EBITDA Margin (2010 - 2026)
Conmed (CNMD) posted EBITDA Margin of 8.02% for Q1 2026, down 18.32% on a QoQ basis from 9.81% in Q4 2025, and up 305.0% year-over-year from 1.98% in Q1 2025.
Conmed (CNMD) EBITDA Margin (2010 - 2026) Analysis & Trends
Conmed's EBITDA Margin history runs 17 years deep, the most recent figure standing at 8.02% for Q1 2026.
- Quarterly EBITDA Margin rose 305.0% year-over-year to 8.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.18% (down 560.0% YoY) and the FY2025 annual result came in at 7.46%, down 786.0% from the prior year.
- EBITDA Margin was 8.02% for Q1 2026 at Conmed, down from 9.81% in the prior quarter.
- Across five years, EBITDA Margin topped out at 20.75% in Q3 2024 and bottomed at 0.44% in Q4 2022.
- A 5-year average of 9.62% and a median of 9.26% in 2022 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2023 — EBITDA Margin surged 1578 bps — and 2025, when it tumbled 1723 bps.
- Conmed's EBITDA Margin stood at 0.44% in 2022, then soared by 3616 bps to 15.35% in 2023, then fell by 1 bps to 15.18% in 2024, then slumped by 35 bps to 9.81% in 2025, then slipped by 18 bps to 8.02% in 2026.
- Business Quant data shows CNMD's EBITDA Margin at 8.02% in Q1 2026, 9.81% in Q4 2025, and 3.52% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Conmed | 1.29 Bn | 1.26 Bn | 183.45 Mn | 8.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.02% |
| Dec 31, 2025 | 9.81% |
| Sep 30, 2025 | 3.52% |
| Jun 30, 2025 | 11.15% |
| Mar 31, 2025 | 4.97% |
| Dec 31, 2024 | 15.18% |
| Sep 30, 2024 | 20.75% |
| Jun 30, 2024 | 14.18% |
| Mar 31, 2024 | 11.21% |
| Dec 31, 2023 | 15.35% |
| Sep 30, 2023 | 9.95% |
| Jun 30, 2023 | 8.63% |
| Mar 31, 2023 | 4.30% |
| Dec 31, 2022 | -0.44% |
| Sep 30, 2022 | 8.81% |
| Jun 30, 2022 | 8.82% |
| Mar 31, 2022 | 9.26% |
| Dec 31, 2021 | 13.58% |
| Sep 30, 2021 | 10.73% |
| Jun 30, 2021 | 10.07% |